ImmunityBio, Inc.
IBRX
$7.25
$0.081.12%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 518.40% | 62.09% | 97.76% | -29.51% | -63.88% |
| Total Receivables | 147.95% | 1,506.37% | 587.54% | 983.98% | 716.71% |
| Inventory | -93.52% | -89.00% | 242.34% | 266.65% | -- |
| Prepaid Expenses | 38.90% | 0.71% | 25.02% | 39.89% | 20.87% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 15.87% | 64.05% | 14.35% | 0.04% | -31.87% |
| Total Current Assets | 314.93% | 70.58% | 101.96% | -14.29% | -44.23% |
|
|
|||||
| Total Current Assets | 314.93% | 70.58% | 101.96% | -14.29% | -44.23% |
| Net Property, Plant & Equipment | -12.56% | -13.44% | -6.40% | -4.42% | -6.55% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | -- | -- |
| Goodwill | 0.00% | 0.00% | 0.00% | -- | -- |
| Total Other Intangibles | -17.60% | -13.18% | -12.87% | -12.40% | -12.30% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 204.52% | 0.53% | 4.92% | 6.15% | 18.37% |
| Total Assets | 112.88% | 31.07% | 42.36% | -9.51% | -24.19% |
|
|
|||||
| Total Accounts Payable | -17.10% | 3.76% | -41.95% | -63.48% | -2.65% |
| Total Accrued Expenses | 75.36% | 9.75% | -0.95% | 0.04% | -16.60% |
| Short-term Debt | -- | 40.30% | 20.34% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.94% | 1.62% | 4.73% | 18.66% | 21.80% |
| Total Finance Division Other Current Liabilities | 25.26% | 179.97% | -2.32% | 15.20% | 6.75% |
| Total Other Current Liabilities | 25.26% | 179.97% | -2.32% | 15.20% | 6.75% |
| Total Current Liabilities | 38.10% | 12.39% | -6.28% | -18.46% | -8.47% |
|
|
|||||
| Total Current Liabilities | 38.10% | 12.39% | -6.28% | -18.46% | -8.47% |
| Long-Term Debt | 38.45% | 7.43% | -16.02% | -16.43% | -8.05% |
| Short-term Debt | -- | 40.30% | 20.34% | -- | -- |
| Capital Leases | 0.79% | -3.30% | -6.50% | -0.92% | -13.36% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1,008.29% | 197.98% | 250.31% | -1.01% | -79.94% |
| Total Liabilities | 69.50% | 14.97% | -5.98% | -14.87% | -18.08% |
|
|
|||||
| Common Stock & APIC | 19.65% | 10.82% | 21.96% | 19.04% | 20.37% |
| Retained Earnings | -24.38% | -10.41% | -10.51% | -11.36% | -13.21% |
| Treasury Stock & Other | 37.57% | 2,317.03% | 4,751.46% | 157,200.00% | 285,185.71% |
| Total Common Equity | -47.10% | -2.32% | 29.64% | 18.28% | 14.53% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -47.10% | -2.32% | 29.64% | 18.28% | 14.53% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -7.27% | -7.64% | -7.81% | -7.83% | -7.77% |
| Total Equity | -47.19% | -2.34% | 29.66% | 18.29% | 14.54% |
|
|
|||||